Gene therapy for the fetus: is there a future?

Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 22, Issue 1, 2008, Pages 203-218

  David, Anna L ^a   Peebles, Donald ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

congenital disease; fetus; gene therapy; gene transfer

Indexed keywords

ADENOVIRUS VECTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; LENTIVIRUS VECTOR; LIPOSOME; NAKED DNA; PARVOVIRUS VECTOR; POLYETHYLENEIMINE; RETROVIRUS VECTOR; VIRUS VECTOR;

CELL POPULATION; CLINICAL TRIAL; CYSTIC FIBROSIS; DEGENERATIVE DISEASE; DUCHENNE MUSCULAR DYSTROPHY; FETAL GENE THERAPY; FETAL THERAPY; FETUS; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC DISORDER; HEMOPHILIA; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; MINIMALLY INVASIVE SURGERY; NEOPLASM; NONHUMAN; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; STEM CELL; VASCULAR DISEASE; VIRAL GENE DELIVERY SYSTEM;

FETAL DISEASES; FETAL THERAPIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC DISEASES, INBORN; GENETIC VECTORS; HUMANS;

EID: 39049091406     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2007.08.008     Document Type: Review

References (88)

1. Blaese R.M., Culver K.W., Miller A.D., et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270 (1995) 475-480
2. Clothier C.M. Report of the committee on the ethics of gene therapy CM 1788 (1992), HMSO Publications, London
3. McCandless S.E., Brunger J.W., and Cassidy S.B. The burden of genetic disease on inpatient care in a children's hospital. Am J Hum Genet 74 (2004) 121-127
4. Coutelle C., Douar A.-M., Colledge W.H., et al. The challenge of fetal gene therapy. Nat Med 1 (1995) 864-866
5. Waddington S.N., Mitrophanous K.A., Ellard F., et al. Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice. Gene Ther 10 (2003) 1234-1240
6. MacKenzie T.C., Kobinger G.P., Kootstra N.A., et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 6 (2002) 349-358
7. Chuah M.K., Schiedner G., Thorrez L., et al. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Blood 101 (2003) 1734-1743
8. Bessis N., GarciaCozar F.J., and Boissier M.C. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther 11 (2004) S10-S17
9. Gilchrist S.C., Ontell M.P., Kochanek S., et al. Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector. Mol Ther 6 (2002) 359-368
10. Kamata Y., Tanabe A., Kanaji A., et al. Long-term normalization in the central nervous system, ocular manifestations, and skeletal deformities by a single systemic adenovirus injection into neonatal mice with mucopolysaccharidosis VII. Gene Ther 10 (2003) 406-414
11. Cheng S.H., and Smith A.E. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders. Gene Ther 10 (2003) 1275-1281
12. Waddington S.N., Nivsarkar M.S., Mistry A.R., et al. Permanent phenotypic correction of Hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104 (2004) 2714-2721
13. Wilson J.M., and Wivel N.A. Report on the potential use of gene therapy in utero. Gene Therapy Advisory Committee. Hum Gene Ther 10 (1999) 689-692
14. Lipshutz G.S., Sarkar R., Flebbe-Rehwaldt L., et al. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc Natl Acad Sci U S A 96 (1999) 13324-13329
15. Dejneka N.S., Surace E.M., Aleman T.S., et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 9 (2004) 182-188
16. Seppen J., van der Rijt R., Looije N., et al. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 8 (2003) 593-599
17. Rucker M., Fraites T.J., Porvasnik S.L., et al. Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 131 (2004) 3007-3019
18. Furie B., Limentani S.A., and Rosenfield C.G. A practical guide to the evaluation and treatment of hemophilia. Blood 84 (1994) 3-9
19. Lusher J.M. Inhibitors in young boys with haemophilia. Baillieres Best Pract Res Clin Haematol 13 (2000) 457-468
20. Soucie J.M., Nuss R., Evatt B., et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood 96 (2000) 437-442
21. Snyder R.O., Miao C., Meuse L., et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 5 (1999) 64-70
22. Manno C.S., Pierce G.F., Arruda V.R., et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12 (2006) 342-347
23. Manno C.S., Chew A.J., Hutchison S., et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101 (2003) 2963-2972
24. Gharwan H., Wightman L., Kircheis R., et al. Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA). Gene Ther 10 (2003) 810-817
25. Luton D., Oudrhiri N., De Lagausie P., et al. Gene transfection into fetal sheep airways in utero using guanidinium-cholesterol cationic lipids. J Gene Med 6 (2004) 328-336
26. Fletcher S., Ahmad A., Perouzel E., et al. In vivo studies of dialkynoyl analogues of DOTAP demonstrate improved gene transfer efficiency of cationic liposomes in mouse lung. J Med Chem 49 (2006) 349-357
27. Mason C.A., Bigras J.L., O'Blenes S.B., et al. Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med 5 (1999) 176-182
28. David A.L., Cook T., Waddington S., et al. Ultrasound guided percutaneous delivery of adenoviral vectors encoding the b-galactosidase and human factor IX genes to early gestation fetal sheep in utero. Hum Gene Ther 14 (2003) 353-364
29. Waddington S.N., Buckley S.M.K., Nivsarkar M., et al. In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor. Blood 101 (2003) 1359-1366
30. Lipshutz G.S., Flebbe-Rehwaldt L., and Gaensler K.M.L. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol Ther 2 (2000) 374-380
31. McCray P.B., Armstrong K., Zabner J., et al. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 95 (1995) 2620-2632
32. Chen H.H., Mack L.M., Kelly R., et al. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc Natl Acad Sci U S A 94 (1997) 1645-1650
33. Schiedner G., Morral N., Parks R.J., et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18 (1998) 180-183
34. Murphy S.J., Chong H., Bell S., et al. Novel integrating adenoviral/retroviral hybrid vector for gene therapy. Hum Gene Ther 13 (2002) 745-760
35. Kubo S., and Mitani K. A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector. J Virol 77 (2003) 2964-2971
36. Jerebtsova M., Batshaw M.L., and Ye X. Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice. Pediatr Res 52 (2002) 95-104
37. Bouchard S. Prolonged expression of adenovirus and adeno-associated virus following fetal administration in the preimmune period. Mol Ther 3 (2001) S393-S394
38. Schneider H., Mühle C., Douar A.-M., et al. Sustained delivery of therapeutic concentrations of human clotting factor IX - a comparison of adenoviral and AAV vectors administered in utero. J Gene Med 4 (2002) 46-53
39. Lipshutz G.S., Titre D., Brindle M., et al. Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Mol Ther 8 (2003) 90-98
40. Garrett D.J., Cohen C.J., and Larson J.E. Long term modification of adult physiology following in utero gene transfer using an AAV vector. Genet Vaccines Ther 2 (2004) 4
41. Nakai H., Montini E., Fuess S., et al. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat Genet 34 (2003) 297-302
42. Baschat A.A., Towbin J., Bowles N.E., et al. Is adenovirus a fetal pathogen?. Am J Obstet Gynecol 189 (2003) 758-763
43. Burguete T., Rabreau M., Fontanges-Darriet M., et al. Evidence for infection of the human embryo with adeno-associated virus in pregnancy. Hum Reprod 14 (1999) 2396-2401
44. Walsh C., and Cepko C.L. Widespread dispersion of neuronal clones across functional regions of the cerebral cortex. Science 255 (1992) 434-441
45. Hatzoglou M., Lamers W., Bosch F., et al. Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J Biol 265 (1990) 17285-17293
46. Porada C.D., Tran N., Eglitis M., et al. In utero gene therapy: transfer and long-term expression of the bacterial neor gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther 9 (1998) 1571-1585
47. Tarantal A.F., O'Rourke J.P., Case S.S., et al. Rhesus monkey model for fetal gene transfer: studies with retroviral-based vector systems. Mol Ther 3 (2001) 128-138
48. Miller D.G., Adam M.A., and Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10 (1990) 4239-4242
49. Welsh R.J., Cooper N.R., Jensen F.C., et al. Human serum lyses RNA tumor viruses. Nature 257 (1975) 612-614
50. Engelstädter M., Buchholz C.J., Bobkova M., et al. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins. Gene Ther 8 (2001) 1202-1206
51. Douar A.-M., Themis M., Sandig V., et al. Effect of amniotic fluid on cationic lipid mediated transfection and viral infection. Gene Ther 3 (1996) 789-796
52. Galan H.L., Bennett M.L., Tyson R.W., et al. Inefficient transduction of sheep in utero after intra-amniotic injection of retroviral producer cells. Am J Obstet Gynecol 187 (2002) 469-474
53. Bennett M., Galan H., Owens G., et al. In utero gene delivery by intraamniotic injection of a retroviral vector producer cell line in a nonhuman primate model. Hum Gene Ther 12 (2001) 1857-1865
54. Lewis P., Hensel M., and Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 11 (1992) 3053-3058
55. Park F., Ohashi K., Chiu W., et al. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 24 (2000) 49-52
56. David A.L., Weisz B., Gregory L., et al. Ultrasound-guided injection and occlusion of the trachea in fetal sheep. Ultrasound Obstet Gynecol 28 (2006) 82-88
57. Coutelle C., Themis M., Waddington S.N., et al. Gene therapy progress and prospects: fetal gene therapy - first proofs of concept - some adverse effects. Gene Ther 12 (2005) 1601-1607
58. Larson J.E., Morrow S.L., Delcarpio J.B., et al. Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol Ther 2 (2000) 631-639
59. Tarantal A.F., Lee C.I., Ekert J.E., et al. Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): lung-targeting approaches. Mol Ther 4 (2001) 614-621
60. Pahal G.S., Jauniaux E., Kinnon C., et al. Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation. Am J Obstet Gynecol 183 (2000) 1029-1034
61. Fletcher J.C., and Richter G. Human fetal gene therapy: moral and ethical questions. Hum Gene Ther 7 (1996) 1605-1614
62. Recombinant DNA Advisory Committee. Prenatal gene transfer; scientific, medical, and ethical issues. Hum Gene Ther 11 (2000) 1211-1229
63. Morrow S.L., Larson J.E., Nelson S., et al. Modfication of development by the CFTR gene in utero. Mol Genet Metab 65 (1998) 203-212
64. Hacein-Bey-Abina S., von Kalle C., Schmidt M., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348 (2003) 255-256
65. Juengst E.T. What next for human gene therapy?. Br Med J 326 (2003) 1410-1411
66. Baum C., Kustikova O., Modlich U., et al. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 17 (2006) 253-263
67. Themis M., Waddington S.N., Schmidt M., et al. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 12 (2005) 763-771
68. Billings P.R. In utero gene therapy. Nat Med 5 (1999) 255-256
69. Tran N.D., Porada C.D., Zhao Y., et al. In utero transfer and expression of exogenous genes in sheep. Exp Hematol 28 (2000) 17-30
70. Lipshutz G.S., Gruber C.A., Cao Y., et al. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 3 (2001) 284-292
71. Schneider H., and Coutelle C. In utero gene therapy: the case for. Nat Med 5 (1999) 256-257
72. Coutelle C., and Rodeck C. On the scientific and ethical issues of fetal somatic gene therapy. Gene Ther 9 (2002) 670-673
73. Burger I.M., and Wilfond B.S. Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boards. Hum Gene Ther 11 (2000) 1057-1063
74. Westgren M., Ringden O., Bartmann P., et al. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency. Am J Obstet Gynecol 187 (2002) 475-482
75. Wells D., and Delhanty J.D. Preimplantation genetic diagnosis: applications for molecular medicine. Trends Mol Med 7 (2001) 23-30
76. Snowdon C., and Green J.M. Preimplantation diagnosis and other reproductive options: attitudes of male and female carriers of recessive disorders. Hum Reprod 12 (1997) 341-350
77. Brown P. Regulations not keeping up with developments in genetics, says poll. Br Med J 321 (2000) 1369
78. Muench M.O., Rae J., Barcena A., et al. Transplantation of a fetus with paternal Thy-1(+)CD34(+) cells for chronic granulomatous disease. Bone Marrow Transplant 27 (2001) 355-364
79. Touraine J.L. Induction of transplantation tolerance in humans using stem cell transplants prenatally or postnatally. Transplant Proc 31 (1999) 2735-2737
80. Themis M., Schneider H., Kiserud T., et al. Successful expression of b-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Ther 6 (1999) 1239-1248
81. Nicolini U., Nicolaidis P., Fisk N.M., et al. Fetal blood sampling from the intrahepatic vein: analysis of safety and clinical experience with 214 procedures. J Obstet Gynaecol 76 (1990) 47-53
82. Weisz B., David A.L., Gregory L.G., et al. Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy. Am J Obstet Gynecol 193 (2005) 1105-1109
83. Newnham J.P., Kelly R.W., Boyne P., et al. Ultrasound guided blood sampling from fetal sheep. Aust J Agric Res 40 (1989) 401-407
84. Chinnaiya A., Venkat A., Dawn C., et al. Intraheptatic vein fetal blood sampling: current role in prenatal diagnosis. J Obstet Gynaecol Res 24 (1998) 239-246
85. Wang G., Williamson R., Mueller G., et al. Ultrasound-guided gene therapy to hepatocytes in utero. Fetal Diagn Ther 13 (1998) 197-205
86. David A.L., Peebles D.M., Gregory L., et al. Percutaneous ultrasound-guided injection of the trachea in fetal sheep: a novel technique to target the fetal airways. Fetal Diagn Ther 18 (2003) 385-390
87. Peebles D., Gregory L.G., David A., et al. Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero. Gene Ther 11 (2004) 70-78
88. David A.L., Peebles D.M., Gregory L., et al. Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: toward prenatal prevention of early-onset intestinal diseases. Hum Gene Ther 17 (2006) 767-779